Voermann Karsten has filed 29 insider transactions across 1 company since March 2023.
Most recent transaction: a option exercise of 89292 shares of GoodRx Holdings, Inc. ($GDRX) on January 08, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Class A Common Stock | 89292 | $0.00 | 392,596.0000 | 392,172,000 | 29.44% | 0.02% |
| Jan. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | F | Class A Common Stock | 29035 | $4.41 | 363,561.0000 | 392,172,000 | 7.40% | 0.01% |
| Jan. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Restricted Stock Unit | 89292 | $0.00 | 267,876.0000 | 392,172,000 | 25.00% | 0.02% |
| Dec. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Class A Common Stock | 54064 | $0.00 | 327,963.0000 | 393,477,000 | 19.74% | 0.01% |
| Dec. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | F | Class A Common Stock | 24659 | $4.91 | 303,304.0000 | 393,477,000 | 7.52% | 0.01% |
| Dec. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Restricted Stock Unit | 54064 | $0.00 | 378,448.0000 | 393,477,000 | 12.50% | 0.01% |
| Sept. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Class A Common Stock | 54064 | $0.00 | 298,599.0000 | 410,315,000 | 22.11% | 0.01% |
| Sept. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | F | Class A Common Stock | 24700 | $7.71 | 273,899.0000 | 410,315,000 | 8.27% | 0.01% |
| Sept. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Restricted Stock Unit | 54064 | $0.00 | 432,512.0000 | 410,315,000 | 11.11% | 0.01% |
| June 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Class A Common Stock | 54064 | $0.00 | 266,016.0000 | 410,315,000 | 25.51% | 0.01% |
| June 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | F | Class A Common Stock | 21481 | $8.55 | 244,535.0000 | 410,315,000 | 8.08% | 0.01% |
| June 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Restricted Stock Unit | 54064 | $0.00 | 486,576.0000 | 410,315,000 | 10.00% | 0.01% |
| March 12, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | A | Restricted Stock Unit | 357168 | $0.00 | 357,168.0000 | 410,315,000 | 9999.99% | 0.09% |
| March 12, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | A | Stock Option (Right to Buy) | 515793 | $0.00 | 515,793.0000 | 410,315,000 | 9999.99% | 0.13% |
| March 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Class A Common Stock | 54064 | $0.00 | 229,192.0000 | 410,315,000 | 30.87% | 0.01% |
| March 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | F | Class A Common Stock | 17240 | $7.54 | 211,952.0000 | 410,315,000 | 7.52% | 0.00% |
| March 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Restricted Stock Unit | 54064 | $0.00 | 540,640.0000 | 410,315,000 | 9.09% | 0.01% |
| Dec. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Class A Common Stock | 54064 | $0.00 | 199,885.0000 | 412,858,000 | 37.08% | 0.01% |
| Dec. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | F | Class A Common Stock | 24757 | $5.94 | 175,128.0000 | 412,858,000 | 12.39% | 0.01% |
| Dec. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Restricted Stock Unit | 54064 | $0.00 | 594,704.0000 | 412,858,000 | 8.33% | 0.01% |
| Sept. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Class A Common Stock | 54064 | $0.00 | 165,578.0000 | 412,858,000 | 48.48% | 0.01% |
| Sept. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | F | Class A Common Stock | 19757 | $6.16 | 145,821.0000 | 412,858,000 | 11.93% | 0.00% |
| Sept. 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Restricted Stock Unit | 54064 | $0.00 | 648,768.0000 | 412,858,000 | 7.69% | 0.01% |
| June 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Class A Common Stock | 54064 | $0.00 | 128,125.0000 | 412,858,000 | 73.00% | 0.01% |
| June 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | F | Class A Common Stock | 16611 | $5.41 | 111,514.0000 | 412,858,000 | 12.96% | 0.00% |
| June 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Restricted Stock Units | 54064 | $0.00 | 702,832.0000 | 412,858,000 | 7.14% | 0.01% |
| March 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Class A Common Stock | 54064 | $0.00 | 91,458.0000 | 412,858,000 | 144.58% | 0.01% |
| March 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | F | Class A Common Stock | 17397 | $5.50 | 74,061.0000 | 412,858,000 | 19.02% | 0.00% |
| March 8, 2023 | GoodRx Holdings, Inc. | $GDRX | Voermann Karsten | Chief Financial Officer | M | Restricted Stock Unit | 54064 | $0.00 | 756,896.0000 | 412,858,000 | 6.67% | 0.01% |